Exhibit 99.5
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_001.jpg)
JBS ENDS 3Q24 WITH US(2 BILLION IN EBITDA FREE CASH FLOW OF US(1 BILLION AND NET PROFIT OF US(693 MILLION São Paulo, November 13, 2024 – JBS S.A - (B3: JBSS3; OTCQX: JBSAY), announce S today it S 3Q24 re S ult S . The comment S made herein are in US dollar S , in accordance with international accounting S tandard S (IFRS), unle SS otherwi S e S pecified. Earnings Release JBS (JBSS3) Price on 11.13.2024 R$35.64 Market Value on 11.13.2024 R$79.1 Billion Total Shares: 2,218,116,370 IR Contact Guilherme Cavalcanti Chri S tiane A SS i S Pedro Bueno Felipe Brindo Vitor Figueira Amanda Harumi ri_ir@jbs.com.br 3Q24 HIGHLIGHTS (US() Net Sales: US$19.9 bn (+6.4% y/y) Adjusted EBITDA: US$2.2 bn (+94.3% y/y) Adjusted EBITDA Margin: 10.8% (+4.9 p.p. y/y) Free Cash Flow: US$994.3 mn (+65.1% y/y) Net profit: US$693 mn OPERATIONAL AND FINANCIAL HIGHLIGHTS IN IFRS JBS BEEF NORTH AMERICA Net Sales: US$6.3 bn (+6.0% y/y) Adjusted EBITDA: US$117.3 mn (+13.9% y/y) EBITDA Margin: 1.9% (+0.1 p.p. y/y) JBS AUSTRALIA Net Sales: US$1.8 bn (+13.3% y/y) Adjusted EBITDA: US$174.3 mn (+28.0% y/y) EBITDA Margin: 9.8% (+1.1 p.p. y/y) JBS USA PORK Net Sales: US$2.0 bn (+0.8% y/y) Adjusted EBITDA: US$246.7 mn (+17.9% y/y) EBITDA Margin: 12.1% (+1.8 p.p. y/y) PPC Net Sales: US$4.6 bn (+5.2% y/y) Adjusted EBITDA: US$775.9 mn (+72.5% y/y) EBITDA Margin: 16.9% (+6.6 p.p. y/y) SEARA Net Sales: US$2.2 bn (+4.9% y/y) Adjusted EBITDA: US$461.2 mn (+297.4% y/y) EBITDA Margin: 21.0% (+15.5 p.p. y/y) JBS BRASIL Net Sales: US$3.3 bn (+10.1% y/y) Adjusted EBITDA: US$377.7 mn (+280.5% y/y) EBITDA Margin: 11.6% (+8.2 p.p. y/y) CONSOLIDATED • JBS updated guidance for 2024 , with an e S timated Net Revenue of US $ 77 billion and Adju S ted EBITDA between US $ 6 . 9 billion US $ 7 . 1 billion . • The Company paid dividend S on October 7 in the amount of R $ 4 . 4 billion (US $ 812 million), equivalent to R $ 2 per S hare (US $ 0 . 37 ) . The Company al S o announced that it will pay the amount of R $ 2 . 2 billion, R $ 1 per S hare (US $ 0 . 17 *), on January 15 , 2025 . Additionally, it reopened it S S hare buyback program for up to 113 million S hare S . • JBS reached 2 . 15 x leverage in dollar S at the end of the 3 Q, a very comfortable level for thi S ratio . During the quarter, JBS i SS ued R $ 1 . 5 billion in CRA S (Agribu S ine SS Receivable S Certificate S ) through it S S ub S idiary Seara and redeemed R $ 3 . 9 billion in CRA S i SS ued by JBS . During the quarter, it reduced it S net debt by US $ 1 billion quarter - on - quarter and more than US $ 2 . 3 billion compared to the S ame period la S t year . * Exchange rate of R$5.81 per US$1.00 on 11/13/2024
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_002.jpg)
MESSAGE FROM THE CEO Gilberto Tomazoni, Global CEO JBS 2 The third quarter re S ult S for 2024 reaffirm our po S itive outlook for the year, highlighting once again the S trength of JBS’ global, multi - protein platform, the quality of our team, and our focu S on operational excellence . Net Revenue wa S a record US $ 19 . 9 billion . During thi S period, EBITDA reached US $ 2 . 2 billion, with a con S olidated margin of 10 . 8 % – marking a nearly five percentage point increa S e compared to the S ame quarter in 2023 . The re S ult S pre S ented thi S quarter allow u S to announce that the Company will di S tribute dividend S on January 15 , 2025 , of approximately US $ 0 . 17 per S hare, totaling around US $ 382 million . La S t October, approximately US $ 815 million in dividend S were di S tributed . Over the pa S t S ix year S , the Company ha S delivered an average total return to S hareholder S of approximately 20 % per year in U . S . dollar S , demon S trating our commitment to growth and value di S tribution . Our poultry and pork operation S in Brazil and the United State S performed above expectation S , e S pecially Seara, which clo S ed the quarter with a record - breaking 21 % margin . Strong global demand, favorable grain co S t S , and our agility in managing product and market mix, along S ide our focu S on high - value product S and innovation, complement the re S ult S of already implemented operational improvement S in efficiency, productivity, and commercial enhancement S . Pilgrim’ S reported a S olid 16 . 9 % margin, driven by robu S t demand primarily in Europe, the U . S . and Mexico . Operational improvement S and portfolio diver S ification into value - added product S and brand S al S o contributed to the S e re S ult S , along with partner S hip S with key cu S tomer S aimed at delivering value to con S umer S . The bu S ine SS performance al S o reflect S a focu S on quality, S ervice, and innovation . Our US Pork bu S ine SS po S ted a 12 . 1 % margin, driven by higher S ale S both in the U . S . and internationally, along with impre SS ive growth in value - added product S and S trong gain S acro SS agricultural performance metric S . JBS’ multi - geography, multi - protein platform i S unmatched in it S re S ilience amid market challenge S . While the U . S . operation S are S till feeling the effect S of the cattle cycle, JBS Brazil po S ted one of it S be S t performance S , with an 11 . 6 % margin driven by the beef S egment . Beyond the high export volume, Friboi re S ult S reflect the pur S uit of operational excellence, the increa S e in dome S tic demand, the opening of new market S , and the improvement of the product mix, with a focu S on value - added product S , branding, and cu S tomer S ervice . Au S tralia continue S to capture the benefit S of the cattle cycle, with a 9 . 8 % margin in the third quarter de S pite ri S ing live S tock price S . The outlook for thi S bu S ine SS remain S favorable in the coming quarter S . We’re focu S ed on growth fueled by diver S ification, innovation, value - added product S , and S trong branding . Recently, we announced an inve S tment to expand Huon Aquaculture’ S S almon production in Au S tralia . And in Jeddah, Saudi Arabia, we’re fini S hing a new Seara facility that will quadruple local value - added chicken product S capacity in the region . Our Q 3 performance under S core S the S trength of our financial management, a S leverage dropped to 2 . 15 x in USD, net debt wa S reduced by US $ 1 billion, decrea S ing to US $ 13 . 7 billion, and Net Profit came in at US $ 693 million . With our global footprint, the experti S e of our team, ongoing innovation, and a commitment to operational excellence, JBS i S primed to continue delivering value to our cu S tomer S , con S umer S , and S takeholder S alike .
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_003.jpg)
NET REVENUE $19.9Bn FREE CASH FLOW 693 0.05 117 0.31 3T23 3T24 602 994 3T23 3T24 CONSOLIDATED HIGHLIGHTS Note: graph S in million S . ADJUSTED EBITDA $2.2Bn NET PROFIT $693Mn Earning S per S hare were US$ 0.31 3 18,730 19,926 3Q23 3Q24 2,153 5.9% 1,108 10.8% 3T23 3T24 3Q23 3Q24 3Q23 3Q24 3Q23 3Q24 $994Mn
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_004.jpg)
NET REVENUE ADJUSTED EBITDA CONSOLIDATED HIGHLIGHTS In 3Q24, JBS recorded a con S olidated net revenue of US$19.9 billion, which repre S ent S an increa S e of 6.4% compared to 3Q23. During the period, around 74% of JBS' global S ale S were in the dome S tic market S in which the Company operate S and 26% through export S . In the la S t 12 month S , net revenue reached US$76.7 billion (R$396.6 billion). In 3 Q 24 , JBS' S adju S ted EBITDA reached US $ 2 . 2 billion, a growth of 94 . 3 % y/y, while the EBITDA margin reached 10 . 8 % , an increa S e of 490 ba S i S point S compared to the previou S year . With the exception of JBS Beef North America, which i S facing a challenging cattle cycle, all bu S ine SS unit S S howed improvement compared to the S ame period la S t year, highlight S goe S to Seara, Pilgrim’ S and JBS Bra S il . Thi S re S ult reinforce S the S trength of the diver S ified global platform . In the la S t 12 month S , adju S ted EBITDA reached U$6.4 billion, with an adju S ted EBITDA margin of 8.3%. 3Q24 2Q24 ∆ % 3Q23 ∆ % LTM 3Q24 US$ Million US$ % NR US$ % NR 3Q24 vs 2Q24 US$ % NR 3Q24 vs 3Q23 US$ % NR Net Revenue 19,926.0 100.0% 19,284.2 100.0% 3.3% 18,729.7 100.0% 6.4% 76,658.0 100.0% Co S t of Good S Sold (16,646.1) - 83.5% (16,310.8) - 84.6% 2.1% (16,465.0) - 87.9% 1.1% (65,806.6) - 85.8% Gross Profit 3,279.9 16.5% 2,973.4 15.4% 10.3% 2,264.7 12.1% 44.8% 10,851.4 14.2% Selling Expen S e S (1,217.6) - 6.1% (1,116.1) - 5.8% 9.1% (1,129.0) - 6.0% 7.8% (4,645.5) - 6.1% General and Adm. Expen S e S (487.6) - 2.4% (696.0) - 3.6% - 29.9% (595.6) - 3.2% - 18.1% (2,407.0) - 3.1% Net Financial Income (expen S e) (361.1) - 1.8% (599.6) - 3.1% - 39.8% (376.8) - 2.0% - 4.2% (1,650.0) - 2.2% Equity in earning S of S ub S idiarie S 3.9 0.0% 2.4 0.0% 62.1% 4.0 0.0% - 3.3% (0.5) 0.0% Other Income (expen S e) (20.4) - 0.1% (27.0) - 0.1% - 24.4% (5.2) 0.0% 295.5% (28.8) 0.0% Profit (loss) before taxes 1,197.1 6.0% 537.0 2.8% 122.9% 162.1 0.9% 638.6% 2,119.5 2.8% Income and S ocial contribution taxe S (440.5) - 2.2% (149.2) - 0.8% - (20.6) - 0.1% - (568.3) - 0.7% Minority intere S t (63.7) - 0.3% (59.0) - 0.3% 7.9% (24.2) - 0.1% 163.5% (180.5) - 0.2% Net Income (Loss) 692.9 3.5% 328.8 1.7% - 117.3 0.6% 490.5% 1,370.7 1.8% Adjusted EBITDA 2,153.1 10.8% 1,894.2 9.8% 13.7% 1,108.4 5.9% 94.3% 6,375.8 8.3% Earnings per Share 0.31 0.15 110.8% 0.05 490.5% 0.62 ∆ % 3Q23 ∆ % 2Q24 3Q24 US$ Million 434.7% 141.5 95.1% 387.8 756.6 Net income for the period (including non - controlling intere - 4.2% 376.8 - 39.8% 599.6 361.1 Financial income (expen S e), net - 20.6 195.3% 149.2 440.5 Current and deferred income taxe S 1.3% 535.9 - 0.6% 546.3 542.8 Depreciation and amortization - 3.3% (4.0) 62.1% (2.4) (3.9) Equity in S ub S idiarie S 95.8% 1,070.8 24.8% 1,680.5 2,097.2 (=) EBITDA - 66.8% 23.3 - 5.4% 8.2 7.7 Other income / expen S e S - 0.9 - 17.1% 37.2 30.8 Ree S tructuring - (0.9) - 0.0 0.0 A SS et Impairment - 93.3% 10.5 - 99.1% 75.6 0.7 Antitru S t Agreement S - 2.9% 3.7 - 25.0% 4.8 3.6 Donation S and S ocial project S - 0.0 110.5% 6.2 13.1 Rio Grande do Sul Claim - 0.0 - 81.8 0.0 Fi S cal payment S and in S tallment S 94.3% 1,108.4 13.7% 1,894.2 2,153.1 (=) Adjusted EBITDA LTM 3Q24 1,551.2 1,650.0 568.3 2,210.9 0.5 5,980.9 30.4 91.5 5.4 141.3 25.3 19.3 81.8 6,375.8 4
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_005.jpg)
NET FINANCIAL RESULT In 3Q24, net debt financial expen S e wa S US$191 million. NET RESULTS CASH FLOW FROM OPERATING ACTIVITIES AND FREE CASH FLOW NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES CONSOLIDATED HIGHLIGHTS ¹Include S intere S t expen S e on loan S and financing included under pa SS ive intere S t, and intere S t on financial inve S tment S included under active intere S t. In 3Q24, JBS recorded a net profit of US$693 million. Excluding the non - recurring item S de S cribed in the previou S page, adju S ted net income would be US$730 million. In 3 Q 24 , operating ca S h generation wa S US $ 1 . 9 billion, ver S u S operating ca S h generation of US $ 1 . 3 billion in 3 Q 23 . Thi S evolution i S explained by the improvement in operating performance in virtually all bu S ine SS unit S . Free ca S h flow, after adding property, plant and equipment, intere S t paid and received, and lea S ing, wa S po S itive at US $ 994 . 3 million, an improvement of 65 % compared to the S ame period of the previou S year . In 3 Q 24 , the total value of ca S h flow from JBS' S inve S tment activitie S wa S US $ 311 million, with the main inve S tment being the Purcha S e of Property, Plant and Equipment (CAPEX) . ∆ % 3Q23 ∆ % 2Q24 3Q24 US$ Million - 45.8 - 75.5 (68.7) Exchange rate variation - (57.0) - (332.5) 54.8 Fair value adju S tment S on derivative S - 6.9% (428.8) - 7.5% (432.0) (399.4) Intere S t expen S e¹ 27.3% 77.5 - 18.0% 120.4 98.7 Intere S t income¹ 221.2% (14.5) 49.4% (31.1) (46.4) Taxe S , contribution, fee S and other S - 4.2% (376.8) - 39.8% (599.6) (361.1) Finance income (expense) - 4.6% (285.5) - 6.5% (291.3) (272.3) Intere S t expen S e S from loan S and fi nancing S 235.9% 24.3 202.2% 27.0 81.5 Intere S t income from inve S tment S - 27.0% (261.2) - 27.8% (264.4) (190.8) Net debt financial expense¹ LTM 3Q24 39.0 (214.3) (1,737.5) 411.1 (148.2) (1,650.0) (1,193.0) 180.3 (1,012.7) 5
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_006.jpg)
NET DEBT BRIDGE INDEBTEDNESS 6 (US$ million) CONSOLIDATED HIGHLIGHTS *Con S idering acqui S ition S , Ca S h Margin, non - ca S h item S and Other S . JBS ended the quarter with US $ 3 . 4 billion available in revolving credit line S , without collateral, of which US $ 2 . 9 billion at JBS USA and US $ 450 million at JBS Bra S il . Thu S , the Company' S total availability i S US $ 8 . 6 billion . At the end of 3 Q 24 , net debt wa S US $ 13 . 7 billion, a reduction of approximately US $ 2 . 3 billion when compared to the end of 3 Q 23 . Leverage in dollar S at the end of the quarter wa S 2 . 15 x . Net Debt for the 3 Q 24 ended at US $ 13 . 7 billion, a reduction of US $ 1 billion compared to 2 Q 24 , driven by the quarter' S S trong ca S h generation . Ca S h generation wa S partially off S et by : (i) Capex in the amount of US $ 321 million ; (ii) payment of intere S t in the amount of US $ 295 million ; (iii) US $ 154 million of biological a SS et S ; and (iv) US $ 103 million from commercial lea S ing and (v) US $ 101 million in tax payment S . 154 265 321 103 101 68 57 25 13,721 14,756 (40) Net debt Other* Non Exchange Rate Taxes Lease CAPEX Interest Paid Biological Working Adjusted Net debt 3Q24 recurring Variaton Payments and Received Assets Capital EBITDA 2Q24 2.15x 2.77x (2,153) US$ Million ∆ % 3Q23 ∆ % 2Q24 3Q24 - 12.2% 21,589.9 1.9% Gross Debt 18,958.0 18,612.2 0.7% 1,845.1 112.1% 1,857.8 875.8 (+) Short Term Debt % of the Gro SS Debt (+) Long Term Debt % of the Gro SS Debt ( - ) Ca S h and Equivalent S 0.0% 8.5% 9.8% 4.7% - 13.4% 19,744.9 - 3.6% 17,100.3 17,736.5 0.0% 91.5% 90.2% 95.3% - 5.4% 5,536.6 35.9% 5,237.5 3,852.8 - 14.5% 16,053.3 - 7.0% Net Debt 13,720.5 14,759.4 Leverage 2.15x 2.77x 4.87x
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_007.jpg)
SOURCE BREAKDOWN CURRENCY & COST BREAKDOWN ¹ Include S fund S available in ca S h and revolving guaranteed credit line S from JBS USA and JBS Brazil ² Include S debt S in other currencie S , S uch a S Euro S and Canadian Dollar S CONSOLIDATED HIGHLIGHTS BRL 11.0% 10.45% p.a. USD² 89.0% 5.13% p.a. Bonds 84% Banks 9% CRA 7% Proforma Debt Amortization Schedule (USS Million)¹ PROFORMA INDEBTEDNESS 5,238 1,858 8 22 1,003 989 707 1,379 1,413 2,910 2,600 2,301 745 2,413 884 261 812 19 177 80 14 2,9 2,914 4,686 450 450 Cash and CRA Seara Dividends Cash Pro - Short Term Equivalents Net Cash forma 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 to 2051 2052 2053 Average Proforma Cost 5.72% p.a. Ca S h and equivalent S Revolving credit facilitie S USD 2.9bn in the US Revolving credit facilitie S USD 450 mn in Brazil CRA SEARA Oct/ 2024 Due : 2029 / 2034 / 2040 2041 / 2042 / 2043 / 2044 Payment of Dividend S Oct/2024 Average Term Proforma 10.3 yrs 7
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_008.jpg)
BUSINESS UNITS – IFRS USS BUSINESS UNITS – USGAAP USS BUSINESS UNITS LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 Million Net Revenue 8,609.7 4.9% 2,091.6 - 1.3% 2,222.5 2,194.0 Seara US$ 12,119.3 10.1% 2,959.0 9.3% 2,980.0 3,256.4 JBS Brazil US$ 24,159.1 6.0% 5,953.2 5.3% 5,992.4 6,312.6 JBS Beef North America US$ 6,612.7 13.3% 1,575.2 8.0% 1,651.7 1,784.6 JBS Au S tralia US$ 8,217.0 0.8% 2,026.6 - 5.5% 2,161.9 2,042.5 JBS USA Pork US$ 18,019.5 5.2% 4,356.4 0.6% 4,555.8 4,581.1 Pilgrim' S Pride US$ 663.9 8.1% 140.7 58.3% 96.1 152.1 Other S US$ - 1,743.2 6.5% - 372.9 5.6% - 376.1 - 397.2 Elimination S US$ 76,658.0 6.4% 18,729.7 3.3% 19,284.2 19,926.0 Total US$ Adjusted EBITDA 1,224.3 297.4% 116.1 19.2% 387.1 461.2 Seara US$ 910.3 280.5% 99.3 66.9% 226.3 377.7 JBS Brazil US$ 37.9 13.9% 103.0 304.7% 29.0 117.3 JBS Beef North America US$ 702.5 28.0% 136.2 - 22.8% 225.8 174.3 JBS Au S tralia US$ 995.4 17.9% 209.2 2.7% 240.3 246.7 JBS USA Pork US$ 2,501.5 72.5% 449.8 - 0.9% 782.8 775.9 Pilgrim' S Pride US$ 5.9 - 98.1% - 4.4 - 3.7 - 0.1 Other S US$ - 2.1 - - 0.6 - - 0.6 0.0 Elimination S US$ 6,375.8 94.3% 1,108.4 13.7% 1,894.2 2,153.1 Total US$ Adjusted EBITDA Margin 14.5% 15.5 p.p. 5.5% 3.6 p.p. 17.4% 21.0% Seara % 7.6% 8.2 p.p. 3.4% 4.0 p.p. 7.6% 11.6% JBS Brazil % 0.2% 0.1 p.p. 1.7% 1.4 p.p. 0.5% 1.9% JBS Beef North America % 10.6% 1.1 p.p. 8.6% - 3.9 p.p. 13.7% 9.8% JBS Au S tralia % 12.1% 1.8 p.p. 10.3% 1.0 p.p. 11.1% 12.1% JBS USA Pork % 14.0% 6.6 p.p. 10.3% - 0.2 p.p. 17.2% 16.9% Pilgrim' S Pride % 0.9% 3.1 p.p. - 3.2% - 3.9 p.p. 3.8% - 0.1% Other S % 8.4% 4.9 p.p. 5.9% 1.0 p.p. 9.8% 10.8% Total % LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 Million Net Revenue 24,159.0 6.0% 5,953.2 5.3% 5,992.4 6,312.6 JBS Beef North America US$ 6,612.8 13.3% 1,575.2 8.0% 1,651.7 1,784.6 JBS Au S tralia US$ 8,216.9 0.8% 2,026.6 - 5.5% 2,161.9 2,042.5 JBS USA Pork US$ 18,034.5 5.2% 4,360.2 0.6% 4,559.3 4,585.0 Pilgrim' S Pride US$ Adjusted EBITDA - 77.0 - 60.6% 93.2 128.0% 16.1 36.7 JBS Beef North America US$ 650.3 39.3% 103.6 - 28.5% 201.7 144.3 JBS Au S tralia US$ 826.9 10.5% 190.3 - 22.9% 272.7 210.3 JBS USA Pork US$ 1,997.7 103.8% 324.0 0.7% 655.9 660.4 Pilgrim' S Pride US$ Adjusted EBITDA Margin - 0.3% - 1.0 p.p. 1.6% 0.3 p.p. 0.3% 0.6% JBS Beef North America % 9.8% 1.5 p.p. 6.6% - 4.1 p.p. 12.2% 8.1% JBS Au S tralia % 10.1% 0.9 p.p. 9.4% - 2.3 p.p. 12.6% 10.3% JBS USA Pork % 11.1% 7.0 p.p. 7.4% 0.0 p.p. 14.4% 14.4% Pilgrim' S Pride % 8
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_009.jpg)
SEARA BUSINESS UNITS In 3 Q 24 , Seara recorded a net revenue of US $ 2 . 2 billion, a growth of 5 % in the annual compari S on . The growth i S explained by higher price S in the period . The S ignificant increa S e of 15 . 5 percentage point S in the EBITDA margin in 3 Q 24 in relation to 3 Q 23 re S ult S from better commercial and operational execution, S trong global demand and expan S ion of the value - added portfolio . Sale S in the dome S tic market, which accounted for 45 % of the unit' S revenue in 3 Q 24 , totaled R $ 5 . 5 billion, 9 % higher than in 3 Q 23 , mainly due to higher price S compared to 3 Q 23 . De S pite revenue growth in all categorie S (poultry, pork and prepared food S ), the main highlight wa S the in natura category . The poultry category grew by 18 % y/y and the pork category grew by 17 % , driven by price increa S e S . In relation to prepared food S , net revenue increa S ed by 2 % , due to higher volume S S old . Seara continue S with it S S trategy of winning con S umer preference through product quality, innovation, execution and brand S trengthening, achieving growth in penetration and repurcha S e rate S . De S pite the negative impact of Newca S tle di S ea S e in the quarter, net revenue in dollar S in the foreign market reached US $ 1 . 2 billion, repre S enting an increa S e of 14 % compared to 3 Q 23 , a S a re S ult of management' S ability to quickly redirect production to other S tate S , which were able to continue exporting . 9 LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 8,609.7 4.9% 100.0% 2,091.6 - 1.3% 100.0% 2,222.5 100.0% 2,194.0 Net Revenue - 76% (6,570.5) - 12.9% - 84% (1,765.0) - 6.1% - 74% (1,637.1) - 70% (1,537.1) Co S t of Good S Sold 24% 2,039.2 101.2% 326.5 16% 12.2% 26% 585.4 30% 656.9 Gro SS Profit 14.5% 1,224.3 297.4% 5.5% 116.1 19.2% 17.4% 387.1 21.0% 461.2 Adjusted EBITDA
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_010.jpg)
Note : On March 1 , 2020 , through a corporate re S tructuring proce SS , Swift S tore S were tran S ferred to the direct S ub S idiary Seara Alimento S . Although the Swift S tore S are part of the corporate S tructure of Seara Alimento S , for the purpo S e S of analy S i S and pre S entation of re S ult S , the Company' S Management decided to allocate Swift' S re S ult S to the JBS Bra S il operating S egment . JBS BRASIL BUSINESS UNITS In 3 Q 24 , JBS Bra S il reported net revenue of US $ 3 . 3 billion (+ 10 % y/y) . Thi S growth reflect S higher S ale S volume S , mainly in the international market . In the export market, beef net revenue grew 34 % y/y in 3 Q 24 , a S a re S ult of the 20 % growth in S ale S volume in the period . In addition to the S trong international demand, geographic diver S ification wa S important in the export market, with S ale S expanding to important region S , S uch a S the Middle Ea S t, the United State S , the Philippine S , among other S . In the dome S tic market, net revenue in the beef category grew 9 % y/y in 3 Q 24 , a S a re S ult of both higher S ale S volume in the period and higher price S . Thi S growth i S mainly attributed to S trong dome S tic demand and the favorable live S tock cycle, re S ulting in greater availability of animal S for S laughter during the quarter . The Company remain S focu S ed on improving execution throughout the value chain, increa S ing and enhancing the level of S ervice to it S commercial and operational partner S . Friboi i S increa S ingly advancing in under S tanding con S umer need S , further expanding it S branded value - added portfolio and bringing even more convenience to it S con S umer S . The Friboi brand wa S once again voted Top of Mind, the mo S t remembered and preferred brand by Brazilian con S umer S , winning the meat category for the fourth time and con S olidating it S po S ition a S the ab S olute leader in it S S ector . According to data publi S hed by CEPEA - ESALQ, the average price of live cattle during the quarter wa S approximately R $ 240 /arroba (+ 5 % y/y) . However, S trong demand during the period, mainly in the international market S , more than off S et thi S increa S e . Thu S , EBITDA totaled US $ 377 . 7 million, with an EBITDA margin of 11 . 6 % in 3 Q 24 . 10 LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 12,119.3 10.1% 100.0% 2,959.0 9.3% 100.0% 2,980.0 100.0% 3,256.4 Net Revenue - 82% (9,906.3) 1.1% - 85% (2,508.1) 4.5% - 81% (2,426.2) - 78% (2,535.4) Co S t of Good S Sold 18% 2,213.0 59.9% 450.9 15% 30.2% 19% 553.8 22% 721.0 Gro SS Profit 7.6% 910.3 280.5% 3.4% 99.3 66.9% 7.6% 226.3 11.6% 377.7 Adjusted EBITDA
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_011.jpg)
LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ USGAAP¹ - US$ Million 100.0% 24,159.0 6.0% 100.0% 5,953.2 5.3% 100.0% 5,992.4 100.0% 6,312.6 Net Revenue - 100% (24,088.8) 7.5% - 97% (5,796.3) 4.7% - 99% (5,950.7) - 99% (6,229.5) Co S t of Good S Sold 70.2 0% - 47.0% 156.9 3% 99.4% 1% 41.7 1% 83.1 Gro SS Profit - 1.1% (254.2) - 0.8% 49.3 - 76.6% - 0.5% (27.4) - 0.1% (6.4) Adjusted EBIT - 0.3% (77.0) - 60.6% 1.6% 93.2 128.0% 0.3% 16.1 0.6% 36.7 Adjusted EBITDA LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 24,159.1 6.0% 100.0% 5,953.2 5.3% 100.0% 5,992.4 100.0% 6,312.6 Net Revenue - 96% (23,244.8) 6.8% - 94% (5,589.9) 3.5% - 96% (5,768.2) - 95% (5,971.4) Co S t of Good S Sold 914.3 4% - 6.1% 363.3 6% 52.2% 4% 224.2 5% 341.2 Gro SS Profit 0.2% 37.9 13.9% 1.7% 103.0 304.7% 0.5% 29.0 1.9% 117.3 Adjusted EBITDA JBS BEEF NORTH AMERICA ¹The difference in JBS Beef North America' S EBITDA in IFRS and USGAAP, in addition to the exchange rate, i S due to the impact S of the adoption of IFRS 16 a S of 1Q19 and different inventory accounting criteria: in IFRS, inventorie S are accounted for at average co S t, while in US GAAP they are BUSINESS UNITS In IFRS and US $ , net revenue in 3 Q 24 wa S US $ 6 . 3 billion, an increa S e of 6 % compared to 3 Q 23 , with adju S ted EBITDA of US $ 117 . 3 million and an EBITDA margin of 1 . 9 % . In USGAAP and US $ , net revenue wa S US $ 6 . 3 billion in 3 Q 24 , an increa S e of 6 % compared to 3 Q 23 , and adju S ted EBITDA wa S US $ 36 . 7 million, with a margin of 0 . 6 % . In the quarter, beef margin S in North America continued to be pre SS ured by the live S tock cycle, de S pite S trong demand in the period . According to data relea S ed by the USDA, fed cattle price S remained at high level S in 3 Q 24 . A S a re S ult, S ince the price of cattle repre S ent S approximately 85 % of the co S t, profitability wa S under pre SS ure during the period . De S pite the increa S ed pre SS ure on margin S due to the cattle cycle, the Company remain S focu S ed on operational and commercial execution in order to protect it S profitability . Initiative S underway include improving pricing, optimizing the product mix, increa S ing yield per carca SS , and increa S ing manufacturing efficiency, among other S . All of the S e action S are e SS ential to face thi S more challenging cycle . marked to market. Volume and price calculation S do not con S ider the impact of acqui S ition S . 11
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_012.jpg)
LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 6,612.7 13.3% 100.0% 1,575.2 8.0% 100.0% 1,651.7 100.0% 1,784.6 Net Revenue - 83% (5,493.8) 11.7% - 85% (1,344.5) 12.7% - 81% (1,332.3) - 84% (1,501.5) Co S t of Good S Sold 17% 1,118.9 22.7% 230.7 15% - 11.4% 19% 319.4 16% 283.1 Gro SS Profit 10.6% 702.5 28.0% 8.6% 136.2 - 22.8% 13.7% 225.8 9.8% 174.3 Adjusted EBITDA LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ USGAAP¹ - US$ Million 100.0% 6,612.8 13.3% 100.0% 1,575.2 8.0% 100.0% 1,651.7 100.0% 1,784.6 Net Revenue - 89% (5,865.5) 11.2% - 92% (1,448.6) 13.1% - 86% (1,424.1) - 90% (1,610.2) Co S t of Good S Sold 747.3 11% 37.7% 126.6 8% - 23.4% 14% 227.6 10% 174.4 Gro SS Profit 8.5% 561.3 48.9% 5.2% 82.1 - 32.1% 10.9% 180.0 6.8% 122.2 Adjusted EBIT 9.8% 650.3 39.3% 6.6% 103.6 - 28.5% 12.2% 201.7 8.1% 144.3 Adjusted EBITDA JBS AUSTRALIA ¹The difference in JBS Au S tralia' S EBITDA in IFRS and USGAAP, in addition to the exchange rate, i S due to the impact S of the adoption of IFRS 16 from 1Q19 and different accounting criteria for biological a SS et S , in IFRS they are marked to market, while in USGAAP they are at average co S t. BUSINESS UNITS Con S idering the re S ult S in IFRS and US $ , net revenue in 3 Q 24 wa S US $ 1 . 8 billion (+ 13 % y/y) . Adju S ted EBITDA wa S US $ 174 . 3 million in 3 Q 24 , with an EBITDA margin of 9 . 8 % . In USGAAP and US $ , net revenue wa S US $ 1 . 8 billion (+ 13 % y/y) in 3 Q 24 , thi S growth i S explained by the 8 % increa S e in volume S S old and 5 % increa S e in average price S . Adju S ted EBITDA wa S US $ 144 . 3 million in 3 Q 24 , with an EBITDA margin of 8 . 1 % . The S trong growth in revenue from the beef bu S ine SS compared to 3 Q 23 reflected increa S ed S ale S in both the dome S tic and export market S . The improvement in the EBITDA margin i S a con S equence of increa S ed operational efficiencie S , aimed at reducing co S t S and increa S ing revenue . However, de S pite the ample availability of animal S due to the more favorable cycle, profitability wa S pre SS ured by the increa S e in cattle price S . According to MLA (Meat & Live S tock Au S tralia), cattle price S in Au S tralia grew 25 % year - on - year in 3 Q 24 . In 3 Q 24 , the aquaculture bu S ine SS reported a decrea S e in net revenue due to lower volume S S old, partially off S et by an increa S e in price S . Net revenue from the pork bu S ine SS grew 7 % compared to the S ame period la S t year . Additionally, the improvement in profitability i S a re S ult of gain S in operational efficiency . Primo, the prepared food unit, recorded an increa S e in average price S in the quarter, but thi S wa S off S et by lower volume S S old . In any ca S e, even in the face of continued inflationary pre SS ure S , it reported an increa S e in the US GAAP EBITDA margin compared to the S ame period la S t year . Volume and price calculation S do not con S ider the impact of acqui S ition S . 12
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_013.jpg)
JBS USA PORK ¹The difference in JBS USA Pork' S EBITDA in IFRS and USGAAP, in addition to the exchange rate, i S due to the impact S of the adoption of IFRS 16 from 1 Q 19 and different accounting criteria . In IFRS, biological a SS et S are marked to market and inventorie S are carried at average co S t, while in USGAAP, biological a SS et S are held at average co S t and inventorie S are carried at average co S t . Volume and price calculation S do not con S ider the BUSINESS UNITS In IFRS and US $ , in 3 Q 24 , net revenue wa S R $ 2 . 0 billion, an increa S e of 1 % compared to 3 Q 23 , and adju S ted EBITDA wa S US $ 246 . 7 million , with a margin of 12 . 1 % . In USGAAP and US $ , net revenue wa S US $ 2 . 0 billion, an increa S e of 1 % compared to 3 Q 23 . Adju S ted EBITDA totaled US $ 210 . 3 million in 3 Q 24 , with a margin of 10 . 3 % . In the dome S tic market, the increa S e in revenue i S a re S ult of higher S ale S volume, driven by S trong S ea S onal demand . Pork con S umption i S al S o being favored by the average price of beef, which remain S at high level S . In the international market, USDA data for the year to date indicate S a 9 % increa S e in S ale S of pork export S , e S pecially to Mexico, South Korea and Colombia . In addition to the improvement in trade dynamic S , the quarter' S profitability wa S po S itively impacted by lower grain co S t S , ongoing effort S to expand the value - added portfolio, and con S i S tent commercial, operational and logi S tical execution . impact of acqui S ition S . 13 LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 8,217.0 0.8% 100.0% 2,026.6 - 5.5% 100.0% 2,161.9 100.0% 2,042.5 Net Revenue - 83% (6,784.1) - 1.2% - 85% (1,715.3) - 6.5% - 84% (1,813.3) - 83% (1,695.3) Co S t of Good S Sold 17% 1,432.9 11.5% 311.3 15% - 0.4% 16% 348.6 17% 347.2 Gro SS Profit 12.1% 995.4 17.9% 10.3% 209.2 2.7% 11.1% 240.3 12.1% 246.7 Adjusted EBITDA LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ USGAAP¹ - US$ Million 100.0% 8,216.9 0.8% 100.0% 2,026.6 - 5.5% 100.0% 2,161.9 100.0% 2,042.5 Net Revenue - 90% (7,367.3) - 0.9% - 91% (1,841.0) - 3.3% - 87% (1,887.7) - 89% (1,825.3) Co S t of Good S Sold 849.6 10% 17.1% 185.6 9% - 20.8% 13% 274.2 11% 217.2 Gro SS Profit 7.7% 635.2 7.6% 7.5% 152.1 - 27.5% 10.4% 225.9 8.0% 163.7 Adjusted EBIT 10.1% 826.9 10.5% 9.4% 190.3 - 22.9% 12.6% 272.7 10.3% 210.3 Adjusted EBITDA
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_014.jpg)
PILGRIM’S PRIDE CORPORATION ¹A diferença no EBITDA entre o S re S ultado S em IFRS e USGAAP da PPC, além do câmbio, S e deve ao S impacto S da adoção do IFRS 16 a partir do 1 T 19 e a critério S diferente S de contabilização da amortização da S ave S matrize S : em IFRS, a amortização do ativo biológico, por S eu caráter de mai S longo prazo, é con S iderada uma de S pe S a pa SS ível de aju S te no EBITDA, enquanto em USGAAP a amortização do ativo biológico é contabilizada BUSINESS UNITS LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ IFRS - US$ Million 100.0% 18,019.5 5.2% 100.0% 4,356.4 0.6% 100.0% 4,555.8 100.0% 4,581.1 Net Revenue - 83% (15,013.4) - 3.2% - 87% (3,791.7) 0.9% - 80% (3,638.9) - 80% (3,670.9) Co S t of Good S Sold 17% 3,006.1 61.2% 564.7 13% - 0.7% 20% 916.9 20% 910.2 Gro SS Profit 14.0% 2,501.5 72.5% 10.3% 449.8 - 0.9% 17.2% 782.8 16.9% 775.9 Adjusted EBITDA no Cu S to do Produto Vendido e não é aju S tada no EBITDA. 14 LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % NR US$ YoY % NR US$ QoQ % NR US$ % NR US$ USGAAP¹ - US$ Million 100.0% 18,034.5 5.2% 100.0% 4,360.2 0.6% 100.0% 4,559.3 100.0% 4,585.0 Net Revenue - 88% (15,954.0) - 2.8% - 92% (4,014.3) 0.9% - 85% (3,867.7) - 85% (3,901.0) Co S t of Good S Sold 12% 2,080.6 97.7% 345.9 8% - 1.1% 15% 691.6 15% 684.0 Gro SS Profit 8.7% 1,563.5 150.3% 5.0% 219.7 0.4% 12.0% 548.0 12.0% 549.9 Adjusted EBIT 11.1% 1,997.7 103.8% 7.4% 324.0 0.7% 14.4% 655.9 14.4% 660.4 Adjusted EBITDA In IFRS and US $ , in 3 Q 24 , net revenue wa S US $ 4 . 6 billion, a growth of 5 % compared to the S ame period of the previou S year, and adju S ted EBITDA of US $ 775 . 9 million, with an EBITDA margin of 16 . 9 % . In US GAAP and US $ , PPC' S net revenue in 3 Q 24 wa S US $ 4 . 6 billion, 5 % higher than 3 Q 23 , and adju S ted EBITDA wa S US $ 660 . 4 million with a margin of 14 . 4 % . Throughout the quarter, the Company continued to focu S on operational excellence, portfolio diver S ification and cultivating partner S hip S with key Cu S tomer S to drive value for the con S umer . The focu S on quality, S ervice and innovation i S reflected in the re S ult S . In the United State S , profitability benefited from high demand, improvement S in production efficiencie S and lower input co S t S . Furthermore, the chicken portfolio grew above the market due to the partner S hip with key Cu S tomer S through differentiated and cu S tomized offer S . The prepared food S category expanded it S market pre S ence, with increa S ed di S tribution in retail and food S ervice . In Mexico, de S pite the S ea S onality of the period, the Company continue S to advance in it S S trategy to capture market opportunitie S . To thi S end, it S trengthened it S partner S hip S with key Cu S tomer S , further diver S ify it S portfolio though brand S and implemented project S to expand capacity, increa S e operational efficiency and mitigate health ri S k S . Adju S ted EBITDA in Europe increa S ed approximately 40 % compared to the S ame period la S t year . Thi S improvement reflect S : (i) continued focu S on operational excellence ; (ii) improvement of the product mix with key Cu S tomer S ; and (iii) inve S tment S in innovation and branded product S .
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_015.jpg)
99 226 378 3.4% 5.9% 4.5% 176 130 7.6% 11.6% 3Q23 4Q23 1Q24 2Q24 3Q24 116 135 241 387 461 5.5% 6.4% 11.6% EBITDA (millions) and % EBITDA 21.0% 17.4% 3Q23 4Q23 1Q24 2Q24 3Q24 3.0 3.0 2.9 3.0 3.3 3Q23 4Q23 1Q24 2Q24 3Q24 JBS Brasil (IFRS - US$) 2.1 2.1 2.1 2.2 2.2 3Q23 4Q23 1Q24 2Q24 3Q24 Seara (IFRS - US$) 324 310 372 656 660 7.4% 6.8% 8.5% EBITDA (millions) and % EBITDA 14.4% 14.4% 3Q23 4Q23 1Q24 2Q24 3Q24 4.4 4.5 4.4 4.6 4.6 3Q23 4Q23 1Q24 2Q24 3Q24 3Q23 4Q23 1Q24 2Q24 3Q24 3Q23 4Q23 1Q24 2Q24 3Q24 Pilgrim's Pride (USGAAP - US$) JBS USA Pork (USGAAP - US$) 190 188 156 273 210 9.4% 9.0% 8.1% 12.6% 10.3% 3Q23 4Q23 1Q24 2Q24 3Q24 2.0 2.1 1.9 2.2 2.0 3Q23 4Q23 1Q24 2Q24 3Q24 1.6 1.7 1.4 1.7 1.8 JBS Australia (USGAAP - US$) 93 - 141 11 16 37 1.6% - 2.3% 0.2% 0.3% 0.6% 3Q23 4Q23 1Q24 2Q24 3Q24 6.0 6.3 5.6 6.0 6.3 3Q23 4Q23 1Q24 2Q24 3Q24 JBS Beef North America (USGAAP - US$) 104 172 132 202 144 6.6% 9.1% 8.1% EBITDA (millions) and % EBITDA 12.2% 9.9% 18.7 19.4 18.0 19.3 19.9 3Q23 4Q23 1Q24 2Q24 3Q24 1,298 1,108 1,030 1,894 2,153 5.9% 5.3% 7.2% 9.8% 10.8% 3Q23 4Q23 1Q24 2Q24 3Q24 BUSINESS UNITS Net Revenue (billions) EBITDA (millions) and % EBITDA Net Revenue (billions) Net Revenue (billions) Net Revenue (billions) EBITDA (millions) and % EBITDA Net Revenue (billions) Net Revenue (billions) EBITDA (millions) and % EBITDA Consolidated (IFRS - US$) Net Revenue (billions) EBITDA (millions) and % EBITDA 15
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_016.jpg)
Greater China¹ 23.0% 16 USA 16.6% Africa & Middle Ea S t 13.1% Japan 9.1% South Korea 7 . 3 % E.U. 7.3% Other S 23.6% US$ 5.3 Billion USA 12.1% Africa & Middle Ea S t 11.9% Japan 8.2% South Korea 7 . 8 % E.U. 6.9% Others 26.1% US$ 4.8 Billion 3Q23 Greater China¹ 27.1% Note 1 Con S ider S China and Hong Kong 3Q24 +8.9% GRAPHIC 1 | JBS EXPORTS IN 3Q24 AND 3Q23 TABLE 1 | CAPEX TABLE 2 | COGS BREAKDOWN TABLES AND GRAPHICS PPC JBS USA Pork JBS Australia JBS Beef North America Seara JBS Brazil Consolidated 3Q24 (%) 49.4% 70.7% 75.8% 89.8% 66.7% 87.5% 77.2% Raw material (live S tock) 32.5% 13.8% 7.1% 4.7% 20.9% 7.4% 12.6% Proce SS ing (including ingredient S and packaging) 18.1% 15.6% 17.1% 5.6% 12.4% 5.1% 10.2% Labor Co S t LTM 3Q24 ∆ % 3Q23 ∆ % 2Q24 3Q24 % CAPEX US$ YoY % CAPEX US$ QoQ % CAPEX US$ % CAPEX US$ US$ Million 100,0% 1.352,5 - 14,5% 100,0% 375,5 - 7,2% 100,0% 345,6 100,0% 320,9 Total Capex 42% 562,1 - 29,1% 48% 180,2 0,3% 37% 127,2 40% 127,6 Expan S ion and Modernization 58% 790,4 - 1,1% 52% 195,3 - 11,5% 63% 218,3 60% 193,2 Maintenance
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_017.jpg)
FINANCIAL STATEMENTS 17 BALANCE SHEET Consolidated In million of American Dollars - US$ 12/31/23 09/30/24 Current Assets 4,570 5,070 Ca S h and ca S h equivalent S 132 167 Margin ca S h 3,391 3,392 Trade account S receivable 5,101 5,472 Inventorie S 1,712 1,590 Biological a SS et S 919 673 Recoverable taxe S 88 92 Derivative a SS et S 323 365 Other current a SS et S 16,236 16,821 TOTAL CURRENT ASSETS 12/31/23 09/30/24 Non - Current Assets 1,744 1,537 Recoverable taxe S 531 527 Biological a SS et S 119 108 Related party receivable S 775 444 Deferred income taxe S 82 - Derivative a SS et S 319 325 Other non - current a SS et S 3,570 2,942 57 45 Inve S tment S in equity - accounted inve S tee S 12,918 12,371 Property, plant and equipment 1,706 1,631 Right of u S e a SS et 1,986 1,930 Intangible a SS et S 6,105 5,848 Goodwill 26,342 24,767 TOTAL NON - CURRENT ASSETS 42,578 41,588 TOTAL ASSETS
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_018.jpg)
BALANCE SHEET Consolidated In million of American Dollars - US$ 12/31/23 09/30/24 Current Liabilities 5,257 4,685 Trade account S payable 948 1,116 Supply chain finance 892 1,858 Loan S and financing 83 167 Income taxe S 144 134 Other taxe S payable 1,297 1,461 Payroll and S ocial charge S 353 346 Lea S e liabilitie S 0 814 Dividend S payable 197 210 Provi S ion S for legal proceeding S 144 102 Derivative liabilitie S 581 558 Other current liabilitie S 9,897 11,451 TOTAL CURRENT LIABILITIES 12/31/23 09/30/24 Non - Current Liabilities 19,108 17,100 Loan S and financing 94 86 Income and other taxe S payable 491 410 Payroll and S ocial charge S 1,489 1,425 Lea S e liabilitie S 1,360 1,235 Deferred income taxe S 316 271 Provi S ion for legal proceeding S - 39 Derivative liabilitie S 116 90 Other non - current liabilitie S 22,973 20,656 TOTAL NON - CURRENT LIABILITIES 12/31/23 09/30/24 Equity 13,178 13,178 Share capital - common S hare S (186) (178) Capital re S erve (36) (37) Other re S erve S 3,624 3,624 Profit re S erve S (7,554) (8,590) Accumulated other comprehen S ive lo SS - 555 Retained Profit 9,025 8,551 Attributable to company shareholders 683 929 Attributable to non - controlling interest 9,708 9,480 TOTAL EQUITY 42,578 41,588 TOTAL LIABILITIES AND EQUITY FINANCIAL STATEMENTS 18
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_019.jpg)
Consolidated In million of American Dollars - US$ 3Q23 18,730 3Q24 19,926 NET REVENUE (16,465) (16,646) Co S t of S ale S 2,265 3,280 GROSS PROFIT (1,129) (1,218) Selling expen S e S (596) (488) General and admini S trative expen S e S (23) (42) Other expen S e S 18 22 Other income (1,730) (1,726) NET OPERATING EXPENSES 535 1,554 OPERATING PROFIT 123 153 Finance income (500) (515) Finance expen S e (377) (361) NET FINANCE EXPENSE 4 4 Share of profit of equity - accounted inve S tee S , net of tax 162 1,197 PROFIT BEFORE TAXES (98) (142) Current income taxe S 77 (298) Deferred income taxe S (21) (441) TOTAL INCOME TAXES 142 757 NET INCOME ATTRIBUTABLE TO: 117 693 Company S hareholder S 24 64 Non - controlling intere S t 142 757 0.05 0.31 Basic and diluted earnings (loss) per share - common shares (US$) INCOME STATEMENT Statements of income for the three month period ended September 30 FINANCIAL STATEMENTS 19
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_020.jpg)
Statements of cash flows for the three months period ended September 30 ted Consolida In million of American Dollars - US$ 3Q23 3Q24 Cash flow 142 757 Net Income (loss) Adjustments for: 536 543 Depreciation and amortization 3 3 Expected Credit Lo SS e S (4) (4) Share of profit of equity - accounted inve S tee S 2 0 Gain on S ale S of a SS et S 21 441 Tax expen S e 377 361 Net finance expen S e 2 3 Share - ba S ed compen S ation 44 9 Provi S ion S for legal proceeding S 0 13 Impairment lo SS (15) 22 Net realizable value inventory adju S tment S (10) (26) Fair value adju S tment of biological a SS et S 11 1 DOJ (Department of Ju S tice) and antitru S t agreement S 1,108 2,123 Changes in assets and liabilities: 222 (61) Trade account S receivable 97 (282) Inventorie S 88 (6) Recoverable taxe S (53) 10 Other current and non - current a SS et S (113) (154) Biological a SS et S (15) 286 Trade account S payable and S upply chain finance (8) (13) Taxe S paid in in S tallment S 50 107 Other current and non - current liabilitie S (24) (101) Income taxe S paid (60) (57) DOJ and Antitru S t agreement S payment 185 (272) Changes in operating assets and liabilities 1,293 1,851 Cash provided by operating activitiess (249) (487) Intere S t paid 34 55 Intere S t received 1,078 1,418 Net cash flows provided by operating activities Cash flow from investing activities (375) (321) Purcha S e S of property, plant and equipment (4) (2) Purcha S e S and di S po S al S of intangible a SS et S 3 10 Proceed S from S ale of property, plant and equipment (2) (1) Acqui S ition S , net of ca S h acquired 3 2 Dividend S received 0 0 Related party tran S action S (0) - Other S (374) (311) Cash provided used in investing activities Cash flows from financing activities 3,955 1,346 Proceed S from loan S and financing (1,806) (903) Payment S of loan S and financing (101) (103) Payment S of lea S ing contract S (12) (32) Derivative in S trument S received ( S ettled) - - Dividend S paid (0) 0 Dividend S paid to non - controlling intere S t 11 (3) Margin ca S h 2,047 306 Cash provided (used in) by financing activities (45) (33) Effect of exchange rate changes on cash and cash equivalents 2,707 1,380 Net change in ca S h and ca S h equivalent S 2,643 3,690 Ca S h and ca S h equivalent S at the beggining of period 5,350 5,070 Cash and cash equivalents at the end of period FINANCIAL STATEMENTS CASH FLOW STATEMENT 20
![](https://capedge.com/proxy/6-K/0001213900-24-098133/ex99-5_021.jpg)
DISCLAIMER We make S tatement S about future event S that are S ubject to ri S k S and uncertaintie S . Such S tatement S are ba S ed on the belief S and a SS umption S of our Management and information to which the Company currently ha S acce SS . Statement S about future event S include information about our current intention S , belief S or expectation S , a S well a S tho S e of the member S of the Company' S Board of Director S and Officer S . Di S claimer S with re S pect to forward - looking S tatement S and information al S o include information on po SS ible or pre S umed operating re S ult S , a S well a S S tatement S that are preceded, followed or that include the word S "believe,“ "may," "will," "continue," “expect S ,“ "predict S ," "intend S ," "plan S ," "e S timate S ," or S imilar expre SS ion S . Forward - looking S tatement S and information are not guarantee S of performance . They involve ri S k S , uncertaintie S and a SS umption S becau S e they refer to future event S , depending, therefore, on circum S tance S that may or may not occur . Future re S ult S and S hareholder value creation may differ materially from tho S e expre SS ed or implied by the forward - looking S tatement S . Many of the factor S that will determine the S e re S ult S and value S are beyond our ability to control or predict . 21